medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2022, Number 4

<< Back Next >>

Arch Neurocien 2022; 27 (4)

Realidad virtual inmersiva para la rehabilitación de la enfermedad de Parkinson: una revisión narrativa

Rojas-Bustamante E, Adalid-Peralta LV

Language: Spanish
References: 34
Page: 57-64
PDF size: 376.44 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Saavedra J, Millán P, Buriticá O. Introducción, epidemiologíay diagnóstico de la enfermedad de Parkinson. Acta NeurolColomb. 2019; 35(1): 2-10. doi:10.22379/24224022244

  2. Cóndor I, Atencio-Paulino J, Contreras-Cordova C.Características clínico epidemiológicas de la enfermedad deParkinson en un hospital nacional de la sierra peruana. RevFac Med Hum. 2019; 19(4):14-21. doi:10.25176/RFMH.v19i4.2342

  3. Carrillo F. Enfermedad de Parkinson y parkinsonismos. Medicine- Programa de Formación Médica Continuada Acreditado.2019; 12(73): 4273–84. doi:10.1016/j.med.2019.03.002

  4. Martínez-Fernández R, Gasca-Salas C, Sánchez-Ferro Á,Ángel-Obeso J. Actualización en la enfermedad de Parkinson.Rev Med Clin Condes. 2016; 27(3): 363-79. doi:10.1016/j.rmclc.2016.06.010

  5. Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, CoelhoM, et al. The Movement Disorder Society Evidence-BasedMedicine Review Update: Treatments for the motor symptomsof Parkinson’s disease. Mov Disord. 2011; 26 (S3):S2-S41.doi:10.1002/mds.23829

  6. van Nimwegen M, Speelman AD, Hofman-van Rossum EJ,Overeem S, Deeg JHD, Borm FG, et al. Physical inactivity inParkinson’s disease. J Neurol. 2011; 258(12): 2214-21.doi:10.1007/s00415-011-6097-7

  7. Tomlinson CL, Herd CP, Clarke CE, Meek C, Patel S, StoweR, et al. Physiotherapy for Parkinson’s disease: A comparisonof techniques. Cochrane Database Syst Rev. 2014; 2014(6):CD002815. doi:10.1002/14651858.CD002815.pub2

  8. Miller K, Suárez-Iglesias D, Seijo-Martínez M, Ayán C.Fisioterapia para la congelación de la marcha en la enfermedadde Parkinson: revisión sistemática y metaanálisis. Rev Neurol.2020; 70(5): 161-70. doi:10.33588/rn.7005.2019417+

  9. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinsondisease: A review. JAMA. 2019; 323(6): 548-60. doi:10.1001/jama.2019.22360

  10. Georgiev DD, Georgieva I, Gong Z, Nanjappan V, GeorgievGV. Virtual reality for neurorehabilitation and cognitiveenhancement. Brain Sci. 2021; 11(2): 221. doi:10.3390/brainsci11020221

  11. Wu J, Zhang H, Chen Z, Fu R, Yang H, Zeng H, et al. Benefitsof virtual reality balance training for patients with Parkinsondisease: Systematic review, meta-analysis, and meta-regressionof a randomized controlled trial. JMIR Serious Games. 2022;10(1):e30882. doi:10.2196/30882.

  12. Cikajlo I, Peterlin Potisk K. Advantages of using 3D virtual realitybased training in persons with Parkinson’s disease: A parallelstudy. J Neuroeng Rehabil. 2019; 16(1):119. doi:10.1186/s12984-019-0601-1.

  13. Lau YS, Patki G, Das-Panja K, Le WD, Ahmad SO.Neuroprotective effects and mechanisms of exercise in achronic mouse model of Parkinson’s disease with moderateneurodegeneration. Eur J Neurosci. 2011; 33(7):1264-74.doi:10.1111/j.1460-9568.2011.07626.x

  14. Marosi K, Bori Z, Hart N, Sárga L, Koltai E, Radák Z, et al.Long-term exercise treatment reduces oxidative stress in thehippocampus of aging rats. Neuroscience. 2012; 226: 21-8.doi:10.1016/j.neuroscience.2012.09.001.

  15. Cotman CW, Berchtold NC, Christie LA. Exercise builds brainhealth: key roles of growth factor cascades and inflammation.Trends Neurosci. 2007; 30(9):464-72. doi:10.1016/j.tins.2007.06.011. Erratum in: Trends Neurosci. 2007Oct;30(10):489.

  16. Xu X, Fu Z, Le W. Exercise and Parkinson’s disease. Int RevNeurobiol. 2019; 147: 45-74. doi:10.1016/bs.irn.2019.06.003

  17. Dibble LE, Foreman KB, Addison O, Marcus RL, LaStayo PC.Exercise and medication effects on persons with Parkinsondisease across the domains of disability: A randomized clinicaltrial. J Neurol Phys Ther. 2015; 39(2):85-92. doi:10.1097/NPT.0000000000000086

  18. Mak MK, Wong-Yu IS, Shen X, Chung CL. Long-term effects ofexercise and physical therapy in people with Parkinson disease.Nat Rev Neurol. 2017; 13(11):689-703. doi: 10.1038/nrneurol.2017.128. Epub 2017 Oct 13. PMID: 29027544.

  19. Lewis GN, Rosie JA. Virtual reality games for movementrehabilitation in neurological conditions: how do we meet theneeds and expectations of the users? Disabil Rehabil. 2012;34(22):1880-6. doi:10.3109/09638288.2012.670036

  20. Sánchez-Herrera-Baeza P, Cano-de-la-Cuerda R, Oña-SimbañaED, Palacios-Ceña D, Pérez-Corrales J, Cuenca-Zaldivar JN, etal. The impact of a novel immersive virtual reality technologyassociated with serious games in Parkinson’s disease patients onupper limb rehabilitation: A mixed methods intervention study.Sensors (Basel). 2020; 20(8):2168. doi:10.3390/s20082168.

  21. Campo-Prieto P, Cancela-Carral JM, Rodríguez-Fuentes G.Wearable immersive virtual reality device for promoting physicalactivity in Parkinson’s disease patients. Sensors (Basel). 2022;

  22. 22(9):3302. doi:10.3390/s2209330222. Janeh O, Fründt O, Schönwald B, Gulberti A, BuhmannC, Gerloff C, et al. Gait training in virtual reality: Short-termeffects of different virtual manipulation techniques in Parkinson’sdisease. Cells. 2019; 8(5):419. doi:10.3390/cells8050419

  23. Brandín N, Secorro S, Calvo Y, Benyoucef P, Herrero, P, BellostaP. Entrenamiento antigravitatorio e inmersivo de realidadvirtual para la rehabilitación de la marcha en la enfermedadde Parkinson: estudio piloto y de viabilidad. Rev Neurol. 2020;71:447-54. doi:10.33588/rn.7112.2020352

  24. Robles-García V, Corral-Bergantiños Y, Espinosa N, García-Sancho C, Sanmartín G, Flores J, et al. Effects of movementimitation training in Parkinson’s disease: A virtual realitypilot study. Parkinsonism Relat Disord. 2016; 26:17-23.doi:10.1016/j.parkreldis.2016.02.022

  25. Espay A, Baram Y, Dwivedi A, Shukla R, Gartner M, Gaines L, etal. At-home training with closed-loop augmented-reality cueingdevice for improving gait in patients with Parkinson disease.JRRD. 2010; 47(6):573-82. doi:10.1682/JRRD.2009.10.0165

  26. Cikajlo I, Peterlin Potisk K. Advantages of using 3D virtual realitybased training in persons with Parkinson’s disease: A parallelstudy. J Neuroeng Rehabil. 2019; 16(1):119. doi:10.1186/s12984-019-0601-1

  27. Bank PJM, Cidota MA, Ouwehand PEW, Lukosch SG. Patienttailoredaugmented reality games for assessing upper extremitymotor impairments in Parkinson’s disease and stroke. J Med Syst.2018; 42(12):246. doi:10.1007/s10916-018-1100-9

  28. Finley JM, Gotsis M, Lympouridis V, Jain S, Kim A, Fisher BE.Design and development of a virtual reality-based mobilitytraining game for people with Parkinson’s disease. Front Neurol.2021; 11:577713. doi:10.3389/fneur.2020.577713

  29. Chen W, Bang M, Krivonos D, Schimek H, Naval A. Animmersive virtual reality exergame for people with Parkinson’sdisease. Computers helping people with special needs. 2020;12376:138-45. doi:10.1007/978-3-030-58796-3_18

  30. Dockx K, Bekkers EM, Van den Bergh V, Ginis P, Rochester L,Hausdorff JM, et al. Virtual reality for rehabilitation in Parkinson’sdisease. Cochrane Database Syst Rev. 2016; 12(12):CD010760.doi:10.1002/14651858.CD010760.pub2

  31. Gil A, Elizagaray-García I, Ranea Lm Rojas O, Gómez S.Efectividad de los programas de inmersión virtual en lospacientes con enfermedad de Parkinson. Revisión sistemática. Rev Neurol. 2018; 66(03):69-80. doi:10.33588/rn.6603.2017459

  32. Canning CG, Allen NE, Nackaerts E, Paul SS, Nieuwboer A, Gilat M. Virtual reality in research and rehabilitation of gait and balance inParkinson disease. Nat Rev Neurol. 2020; 16(8):409-25. doi:10.1038/s41582-020-0370-2

  33. Weber H, Barr C, Gough C, van den Berg M. How commercially available virtual reality-based interventions are delivered and reported ingait, posture, and balance rehabilitation: A systematic review. Phys Ther. 2020; 100(10): 1805-15. doi:10.1093/ptj/pzaa123

  34. Sevcenko K, Lindgren I. The effects of virtual reality training in stroke and Parkinson’s disease rehabilitation: A systematic review and aperspective on usability. Eur Rev Aging Phys Act. 2022; 19(1):4. doi:10.1186/s11556-022-00283-3




2020     |     www.medigraphic.com